Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine: safety and immunogenicity of a fractional booster dose
Description
CONCLUSIONS: ID boosting provides robust immune responses and is a viable dose-sparing strategy for mRNA COVID-19 vaccines. The favorable side-effect profile supports its potential in reducing vaccine hesitancy. Fractional dosing strategies should be
